Cerebrospinal fluid cells immune landscape in multiple sclerosis

Zijian Li, Yongchao Liu, Aili Jia, Yueran Cui, Juan FengJournal of Translational Medicine 2021 · DOI

Abstract

Our study identified the change in the CNS immune microenvironment of MS cases by analysis of the in silico data using CIBERSORT. Our data may assist in providing directions for further research as to the molecular mechanisms of MS and provide future potential therapeutic targets in treatment.

Introduction: The CSF as a Liquid Biopsy

Multiple Sclerosis (MS) is a debilitating chronic autoimmune disease characterized by immune-mediated attacks on the myelin sheath within the central nervous system (CNS). While the role of inflammatory cells breaching the blood-brain barrier is well-documented, the precise immune landscape within the cerebrospinal fluid (CSF) has remained elusive. Traditional research often focuses on soluble proteins in the CSF or fixed tissue lesions. However, the cells suspended in the CSF offer a unique "liquid biopsy," reflecting the dynamic state of the CNS immune environment. Due to the rarity of these cells, this study utilizes computational deconvolution to map their composition and identify key molecular drivers of the disease.

Methodology and Data Integration

The researchers employed a robust bioinformatics pipeline to analyze transcriptomic data from the EBI ArrayExpress database. Two primary datasets were used: a derivation cohort (E-MTAB-69) comprising 26 MS samples and 18 controls, and a validation cohort (E-MTAB-2374) with 20 MS samples and 13 controls.

Bioinformatics workflow for analyzing CSF immune cell landscapes in MS.

As shown in Figure 5, the methodology centered on CIBERSORT, an algorithm that estimates the relative proportions of 22 immune cell types from bulk RNA expression data. This was integrated with Differential Gene Expression (DEG) analysis using the limma package and functional enrichment studies (GO, KEGG, GSEA, and GSVA). Protein-Protein Interaction (PPI) networks were constructed using STRING and Cytoscape to identify central "hub" genes.

Key Results and the Adaptive Shift

The analysis revealed a significant transformation in the CSF immune landscape of MS patients. The most prominent finding was a substantial increase in plasma cells ($p < 0.001$), the antibody-producing cells of the adaptive immune system. Conversely, there was a significant decrease in innate immune subsets, including monocytes, M2 macrophages, neutrophils, and eosinophils.

Differential gene expression and protein-protein interaction analysis identifying core hub genes.

Figure 6 details the molecular signature of these changes. Panel (a) and (b) illustrate the differential expression profiles between MS and control groups. Through PPI network analysis (Panels c and d), the study identified eight core hub genes—NLRP3, LILRB2, C1QB, CD86, C1QA, CSF1R, IL1B, and TLR2—that were consistently downregulated in MS CSF cells.

Discussion: The Homeostasis Paradox

The downregulation of these eight core genes presents a biological paradox. Genes like IL1B and NLRP3 are typically associated with pro-inflammatory states and are often upregulated in MS brain lesions. Their downregulation in CSF cells suggests a potential negative feedback mechanism, where these cells attempt to maintain CNS homeostasis in the face of surrounding neuroinflammation. Furthermore, pathway analysis highlighted the convergence of the complement and coagulation cascades and systemic lupus erythematosus (SLE) pathways, suggesting shared pathological mechanisms with other autoimmune conditions.

Conclusion and Future Directions

This study provides a comprehensive map of the CSF immune landscape in MS, highlighting a shift from innate to adaptive dominance and identifying a unique eight-gene signature. While limited by the retrospective nature of bulk transcriptomic data, these findings offer a foundation for future research. The authors suggest that moving toward single-cell RNA sequencing (scRNA-seq) and prospective clinical validation will be essential to confirm these genes as viable therapeutic targets or biomarkers for disease progression.

Summary updated

Abstract

Our study identified the change in the CNS immune microenvironment of MS cases by analysis of the in silico data using CIBERSORT. Our data may assist in providing directions for further research as to the molecular mechanisms of MS and provide future potential therapeutic targets in treatment.
BibTeX
@article{li2021cerebrospinal,
  author = {Zijian Li and Yongchao Liu and Aili Jia and Yueran Cui and Juan Feng},
  title = {{Cerebrospinal fluid cells immune landscape in multiple sclerosis}},
  journal = {Journal of Translational Medicine},
  year = {2021},
  doi = {10.1186/s12967-021-02804-7},
}
Figure